🔎 Trials Near Me

Home › Alzheimer's Disease › New York › Queens

Alzheimer's Disease clinical trials in Queens, NY

8 studies for Alzheimer's Disease are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

RecruitingPhase 3
  • Local Institution - 1658, Woodmere · 7 mi away
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

RecruitingPhase 3
  • Five Towns Neurology, PC, Woodmere · 7 mi away
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

RecruitingPhase 3
  • Basil Clinical, Laurelton · 5 mi away
Ages 50 to 90 · All sexes · Updated Sep 21, 2026 · NCT07177352

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

RecruitingPhase 3
  • Five Towns Neurology PC -Woodmere - 923 Broadway, Woodmere · 7 mi away
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

RecruitingPhase 3
  • Walnut Clinical Research, Valley Stream · 7 mi away
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011745

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

RecruitingPhase 3
  • Basil Clinical, Laurelton · 5 mi away
Ages 55 to 80 · All sexes · Updated Sep 10, 2026 · NCT07717411

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

RecruitingPhase 2
  • Basil Clinical ( Site 1065), Queens
Ages 50 to 85 · All sexes · Updated Aug 26, 2026 · NCT07033494

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

RecruitingPhase 3
  • Laurelton Heart Specialists, Rosedale · 5 mi away
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895

About Alzheimer's Disease

Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.

More about Alzheimer's Disease on MedlinePlus

Alzheimer's Disease trials in other cities

Other studies in Queens

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.